US stops AstraZeneca vaccine production at Baltimore plant

US President Joe Biden’s administration on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson’s Covid-19 vaccine from making another vaccine developed by AstraZeneca, the New York Times reported on Saturday.

The administration has put Johnson & Johnson in charge of the troubled manufacturing plant, the report said.


Also read - No money, no vaccine: Poor countries in a quandary


The US Health and Human Services’ extraordinary step will render the Emergent BioSolutions facility solely devoted to making the Johnson & Johnson single-dose vaccine, and is meant to avoid future mix-ups, according to the report, which cites two senior federal health officials.

Johnson & Johnson said it was “assuming full responsibility”, confirming the changes, the report added.